RESTASIS® Ophthalmic Emulsion is a prescription medicine that helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye.

How we use this drug:  Restasis is one of our most commonly prescribed drugs.  In part, this is because dry eyes is a complaint we hear daily from many patients.  Environment, aging changes, prolonged near work, some medications and several diseases contribute to chronically dry eyes.  Restasis is the first drug available to provide sustained relief from dry eye symptoms throughout the day.

While Restasis is approved for treating ocular surface inflammation associated with dry eye, it has also been shown to inhibit various immune responses that present in other diseases.   “Off-label” uses include allergic conjunctivitis, recurrent corneal erosions, and meibomean gland disease.

Supplied: RESTASIS® ophthalmic emulsion is packaged in sterile, preservative-free single-use vials.  Vials are packaged in a polypropylene tray with an aluminum peelable lid.  RESTASIS® is available in two package forms.

    • 30 count
    • 60 count (2 x 30 count packages)

Dose: Instill one drop of Restasis ophthalmic emulsion twice a day in each eye approximately 12 hours apart.

Note:  While the package instructions direct paients to use each vial of drug for just one application, it is common practice to use the same opened vial for a second dose 12 hours after the first.

Pregnancy: (Category C) There are no adequate and well-controlled studies of RESTASIS® in pregnant women. RESTASIS® should be administered to a pregnant woman only if clearly needed.

Children: The safety and efficacy of RESTASIS® ophthalmic emulsion have not been established in pediatric patients below the age of 16.

Side Effects: The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

Warning: RESTASIS® Ophthalmic Emulsion should not be used by patients with active eye infections and has not been studied in patients with a history of herpes viral infections of the eye. RESTASIS® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use.

RESTASIS® should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to the administration of the emulsion.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s